Below is the list of top 5 stock picks of billionaire Masayoshi Son. For a detailed discussion about Masayoshi Son’s investment philosophy and portfolio management strategies, please see Japanese Billionaire Masayoshi Son’s Latest Portfolio: Top 10 Stock Picks.
5. SIGNA Sports United N.V. (NAYSE:SSU)
SB Management’s Stake Value: $42.4 million
Percentage of SB Management’s Portfolio: 4.19%
Number of Hedge Fund Holders: 11
Masayoshi Son’s SB Management initiated a brand new position in SIGNA Sports United N.V. (NAYSE:SSU) during the fourth quarter of 2021. SIGNA operates a well-known sports e-commerce and tech platform in Europe, which includes products related to bikes, tennis, and outdoor and team sports. SIGNA generated €213 million ($235.8 million) of revenue in the December quarter, up 11% from the year-ago period. Furthermore, its active customers topped the 7.4 million level, representing an increase of 76% year-over-year.
4. Learn CW Investment Corporation (NYSE:LCW)
SB Management’s Stake Value: $101 million
Percentage of SB Management’s Portfolio: 10%
Number of Hedge Fund Holders: NA
Learn CW Investment Corporation (NYSE:LCW) is also a newcomer to SB management’s stock portfolio. The firm bought a stake valued at more than $101 million in the company during the December quarter, accounting for 10% of its 13F portfolio’s value. The market capitalization of Learn CW Investment Corporation is currently hovering below the $200 million level and its stock has remained volatile since its debut on the NASDAQ in the fourth quarter of 2021.
Learn Capital was founded in 2008 and focuses exclusively on early-stage and mid-stage investments in the global education sector.
3. AbCellera Biologics Inc. (NASDAQ:ABCL)
SB Management’s Stake Value: $140 million
Percentage of SB Management’s Portfolio: 13.88%
Number of Hedge Fund Holders: 18
SB Management looks bullish over the future fundamentals of AbCellera Biologics Inc. (NASDAQ:ABCL). The firm first invested in the company during the December quarter of 2020, lifted its stake further in the March quarter, and has since left its stake unchanged. The Vancouver, British Columbia-based company is researching and developing human antibodies.
Of the 924 13F-filing hedge funds tracked by Insider Monkey, AbCellera was in 18 portfolios as of December 31, down from 21 positions in the previous quarter. Baker Bros. Advisors was a leading stakeholder in the company.
2. Pacific Biosciences Of California Inc. (NASDAQ:PACB)
SB Management’s Stake Value: $166 million
Percentage of SB Management’s Portfolio: 16.49%
Number of Hedge Fund Holders: 21
Pacific Biosciences Of California Inc. (NASDAQ:PACB) is the second-largest stock holding in SB Management’s 13F portfolio according to its latest quarter filing. The number of long hedge fund positions in Pacific Biosciences has declined for three straight quarters according to data tracked by Insider Monkey. As of December 31, Pacific Biosciences was in 21 hedge funds’ portfolios.
Founded in 2004, Pacific BioSciences is engaged in developing and manufacturing systems for gene sequencing. The company’s share price is down close to 70% over the past 12 months.
1. EQRx, Inc. (NASDAQ:EQRX)
SB Management’s Stake Value: $294 million
Percentage of SB Management’s Portfolio: 29.11%
Number of Hedge Fund Holders: 31
Japanese billionaire Masayoshi Son’s SB Management bought a huge stake in EQRx, Inc. (NASDAQ:EQRX) upon its NASDAQ debut in the December quarter. The firm purchased 43.17 million shares of the company valued at around $294 million as of December 31, accounting for a sizable 29% of the value of its 13F portfolio.
The company aims to build a portfolio of innovative, low-cost treatments and develop unique long-term collaborations with other key industry players. There are two pre-registrational oncology assets (sugemalimab and aumolertinib) in EQRx’s pipeline that have demonstrated positive Phase 3 data for the treatment of advanced non-small-cell lung cancer.
You can also take a look at 10 Dividend Stocks Warren Buffett is Backing in 2022 and 10 Dividend Stocks to Buy According to Billionaire Jeffrey Talpins.
